Physiomics Share News (PYC)

Physiomics secures contract with University of Sheffield

(Sharecast News) - Data science firm Physiomics has been chosen by the University of Sheffield to support a grant-funded project focused on an insect model of cancer treatment.

IN BRIEF: Physiomics wins deal to support client's oncology assets

Physiomics PLC - mathematical modelling company that supports oncology drug development - Wins further contract from existing client Numab Therapeutics AG. Says the project involves pharmacokinetic-pharmacodynamic modelling in support of one of Numab's oncology assets entering the clinic and will help inform dose and scheduling decisions. Chief Executive Officer Peter Sargent comments: "We are thrilled to have this opportunity to continue working with and supporting Numab on this asset through its preclinical stages as it heads into the clinic. Along with the project we announced with them in August 2023, this new project is testament to the continued support we provide and the great relationships we've built."

Physiomics awarded further contract by Numab Therapeutics

(Sharecast News) - Data science company Physiomics said on Monday that it had been awarded a further contract by an existing client.

Physiomics appoints COO Sargent as new CEO; completes restructuring

(Alliance News) - Physiomics PLC shares fell on Monday, after it named Chief Operating Officer Peter Sargent as new chief executive, as Jim Millen becomes non-executive chair.

UK shareholder meetings calendar - next 7 days

Physiomics gets UK government grant for oncology dosing tool project

(Alliance News) - Physiomics PLC on Friday said it has been awarded a grant by Innovate UK and the Office for Life Sciences as part of the UK government's 'advancing precision medicine' programme.

Physiomics receives Innovate UK funding grant

(Sharecast News) - Computational biology firm Physiomics said on Friday that it had been awarded a grant by Innovate UK and the Office for Life Sciences as part of the UK Government's Advancing Precision Medicine programme.

Physiomics shares drop as annual loss widens; revenue falls

(Alliance News) - Physiomics PLC on Thursday kept its outlook upbeat, despite reporting a drop in revenue in what it called a "difficult year."

LONDON MARKET MIDDAY: Stocks stay downbeat; Digital 9 plunges 32%

(Alliance News) - Stock prices in London were lower at midday on Thursday as elevated oil prices added fuel to inflationary fears and supported the higher for longer narrative around global interest rates.

AIM WINNERS & LOSERS: Bradda shares surge on updated resource estimate

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Physiomics brings in chief operating officer; shares soar

(Alliance News) - Physiomics PLC on Monday named Peter Sargent as its new chief operating officer.

AIM WINNERS & LOSERS: Physiomics brings in COO; Ergomed receives bid

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

LONDON MARKET CLOSE: FTSE 100 down amid stubborn US inflation

(Alliance News) - Stock prices in London closed mixed on Thursday, after news that a key US inflation reading came in in line with market expectations.

UPDATE: Physiomics wins new deal following Merck contract extension

(Alliance News) - Physiomics PLC on Thursday said it won its first contract with an unnamed "UK-based biotech client".

IN BRIEF: Physiomics to extend anti-cancer regimen work with Merck

Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Has been awarded a further contract by existing client Merck KGaA involving pre-clinical and clinical modelling and simulation of anti-cancer regimens involving combinations of DNA damage and repair agents. Follows on previous Merck-commissioned projects. Expects the contract award to be completed over the next three months.